Mzt Holdings is Diagnostic Equipment in United States that focus on BladderChek Test business. Founded in 1987. They cover business area such as manufacturer, developer, cancer diagnostic technology, product, marketing, distribution, licensing, urine, bladder cancer, its research and development program, cervical cancer, cervical precancerous condition, breast cancer, prostate cancer, addition, allergy, physician, hospital, clinic, Germany, distributor, Europe.
1987
( 37 years old in 2024 )
BladderChek Test
-
330 Nevada St
Newton, MA 02460
United States
Private
manufacturerdevelopercancer diagnostic technologyproductmarketingdistributionlicensingurinebladder cancerits research and development programcervical cancercervical precancerous conditionbreast cancerprostate canceradditionallergyphysicianhospitalclinicGermanydistributorEurope
* We use standard office opening hours in near Mzt Holdings's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mzt Holdings is Diagnostic Equipment business from United States that founded in 1987 (37 years old in 2024), Mzt Holdings business is focusing on BladderChek Test.
Mzt Holdings headquarter office and corporate office address is located in 330 Nevada St Newton, MA 02460 United States.
Mzt Holdings was founded in United States.
In 2024, Mzt Holdings is currently focus on BladderChek Test sector.
Above is snippet of Google Trends for "BladderChek Test" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mzt Holdings, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
